No specific molecular target characterized

The designation "No specific molecular target characterized" is used for pharmacological agents that do not interact with a discrete protein or nucleic acid to produce a therapeutic effect. Instead, these substances rely on bulk physical or chemical properties, such as the neutralization of hydrochloric acid by antacids or the osmotic retention of water by laxatives like polyethylene glycol (Maton & Burton, 1999; Ford et al., 2014). This category encompasses a diverse range of agents, including medical gases, osmotic diuretics, and topical antiseptics, as well as compounds whose molecular targets remain unknown following phenotypic discovery. Historically, general anesthetics were classified here under the Meyer-Overton hypothesis of non-specific lipid interaction, though modern research has identified specific protein targets for many of these agents (Franks, 2008). Because these drugs lack a specific "lock-and-key" mechanism, their pharmacological activity is often broad, and their safety profiles are typically monitored through systemic physiological parameters rather than molecular biomarkers. This classification is essential for identifying therapies that operate outside the traditional paradigm of targeted molecular pharmacology.

Other names

Unknown targetNon-specific mechanismUncharacterized molecular targetNon-protein targetNon-specific drug actionNon-targeted therapy

Therapeutic effects are achieved through non-specific chemical or physical interactions, such as pH neutralization, osmotic pressure changes, or physical adsorption, rather than high-affinity binding to a specific molecular target (Maton & Burton, 1999; Ford et al., 2014).